Ziconotide is an analgesic agent and has been used to treat neuropathic and non-neuropathic pain. Ziconotide acts by binding to N-type calcium channels situated on the terminal part of primary afferent neurons of the nociceptive pathway therefore reducing synaptic transmission with potent antinociceptive effects.
CAT No: 10-101-62
CAS No:107452-89-1
Synonyms/Alias:Ziconotide;Prialt;omega-conotoxin MVIIA;SNX-111;107452-89-1;omega-Conotoxin M VIIA;Ziconotida;omega-Conopeptide MVIIA (Conus);DRG-0250;UNII-7I64C51O16;HSDB 7609;MFCD00145036;150770-63-1;DTXSID60883174;omega-Conotoxin M VIIA (reduced), cyclic (1-16),(8-20),(15-25)-tris(disulfide);7I64C51O16;H-Cys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-Cy;omega-Conotoxin mviia, conus magus;Ziconotide [USAN:INN];ziconotidum;o-Conotoxin MVIIA;.omega.-conotoxin m viia;ZICONOTIDE (MART.);GTPL2536;CHEMBL4594214;N02BG08;CHEBI:135912;CHEBI:142406;DTXCID901323852;HY-P0062;AKOS015994641;AC-8938;AT42420;HS-2032;FC110295;omega-Conotoxin MVIIA, >=95% (HPLC);CS-0015087;NS00068028;?-Conotoxin M VIIA Acetate; ?-Conopeptide MVIIA Acetate; Prialt Acetate; SNX 111;;L-Cysteinyl-L-lysylglycyl-L-lysylglycyl-L-alanyl-L-lysyl-L-cysteinyl-L-seryl-L-arginyl-L-leucyl-L-methionyl-L-tyrosyl-L-alpha-aspartyl-L-cysteinyl-L-cysteinyl-L-threonylglycyl-L-seryl-L-cysteinyl-L-arginyl-L-serylglycyl-L-lysyl-L-cysteinamide cyclic (1-16),(8-20),(15-25)-tris(disulfide);
1. Myotropic activity of allatostatins in tenebrionid beetles
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More